The Effectiveness of Laserpuncture on Chemotherapy-induced Myelosuppression in Head and Neck Cancer Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Myelosuppression Adult
Interventions
DEVICE

The laser acupuncture

The intervention group in this study receives laser acupuncture therapy using a laser Micropad GL2+ device with an infrared wavelength of 880 nm. The laser acupuncture is applied to specific acupuncture points, namely GV14, LI4, ST36, and SP6 on the body, as well as ear points including MA-TF1 Shenmen, MA-SC5 Liver, MA-IC3 Endocrine, MA-IC8 Spleen, and MA-SC6 Kidney. Treatment is administered once daily for a total of six sessions during the chemotherapy treatment period.

DEVICE

Sham Laser acupuncture

The Control group in this study receives sham laser acupuncture therapy using a laser Micropad GL2+ device with deactivation mode. The sham laser acupuncture is applied to specific acupuncture points, namely GV14, LI4, ST36, and SP6 on the body, as well as ear points including MA-TF1 Shenmen, MA-SC5 Liver, MA-IC3 Endocrine, MA-IC8 Spleen, and MA-SC6 Kidney. Treatment is administered once daily for a total of six sessions during the chemotherapy treatment period.

Trial Locations (1)

10430

Universitas Indonesia, Jakarta Pusat

All Listed Sponsors
lead

Indonesia University

OTHER

NCT07075809 - The Effectiveness of Laserpuncture on Chemotherapy-induced Myelosuppression in Head and Neck Cancer Patients | Biotech Hunter | Biotech Hunter